Many new treatments for metastatic breast cancer are under study. Most of these are drug therapies.
A clinical trial can offer you the chance to try a new treatment and possibly benefit from it. Learning a new drug is better than standard treatment can also help others.
Findings from clinical trials determine whether or not these treatments will become a part of the standard of care for metastatic breast cancer. Some treatments may even go on to be used for early stage breast cancer care.
Some clinical trials compare a new treatment to the standard of care. So, not everyone in the trial gets the new treatment. However, even those who don’t get the new treatment still get the standard treatment, just as they would if they didn’t join the trial.
Talk with your oncologist about clinical trials. But remember, like all aspects of cancer care, the decision to join a clinical trial is a personal one.
Learn more about clinical trials, including how to enroll and the informed consent process.
Find a list of questions to ask your doctor about clinical trials.
Placebos aren’t used in metastatic breast cancer clinical trials. You will get either the new treatment or the standard treatment.
If your medical center doesn't offer clinical trials, you may want to get a referral to a cancer center that does.
BreastCancerTrials.org in collaboration with Susan G. Komen® offers a custom matching service to help you find a clinical trial for people with metastatic breast cancer.
Susan G. Komen® Breast Cancer Clinical Trial Information Helpline
If you or a loved one needs information or resources about clinical trials, call our Clinical Trial Information Helpline at 1-877 GO KOMEN (1-877- 465- 6636) or email firstname.lastname@example.org.
The helpline offers breast cancer clinical trial education and support, such as:
What is Susan G. Komen® doing?
Susan G. Komen® is one of several organizations to support the Reagan-Udall Foundation and the Food and Drug Administration (FDA) in the development of an Expanded Access Navigator website.
The Expanded Access (EA) tool serves as a clearinghouse of information and resources to help patients and their doctors more easily access information that could impact treatment decisions. The EA Navigator explains what EA is, who may be eligible, how the request process works and the regulatory and policy issues around EA.
EA, also known as “compassionate use,” gives patients that have exhausted their treatment options and are not eligible for (or able to participate in) a clinical trial, access to investigational drugs before they have been approved by the FDA.
Metastatic Breast Cancer
Research Fast Facts
Facts for Life: Metastatic Breast Cancer
Breast Cancer Clinical Trial Information Helpline
Metastatic Breast Cancer Progress
Patient Perspective on Clinical Trials
1-877 GO KOMEN(1-877-465-6636)